RHONDA HOSKINS: Open Payments
NPI 1578896692 · WARSAW, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,133 in 64 payments from 13 companies in 2025. Trend: 2023 $1,285 · 2024 $1,962 · 2025 $1,133
Food & beverage: $1,133
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 11 | $181 |
| Tris Pharma Inc | 10 | $160 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $159 |
| Vanda Pharmaceuticals Inc. | 8 | $146 |
| Axsome Therapeutics, Inc. | 4 | $84 |
| Otsuka America Pharmaceutical, Inc. | 4 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $68 |
| Corium, LLC | 5 | $65 |
| Janssen Pharmaceuticals, Inc | 3 | $57 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
Products named: REXULTI, Dyanavel XR, CAPLYTA, FANAPT, Auvelity, TRINTELLIX, Azstarys, SPRAVATO.
Industry payments across IN — which companies pay providers there.
